P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation

Oncogene

Volumn 25, Issue 20, 2006, Pages 2829-2838

  Soria, G ^a   Podhajcer, O ^a   Prives, C ^b   Gottifredi, V ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

DNA repair; p21; PCNA; Proteolysis; Ubiquitination

Indexed keywords

APHIDICOLIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; HYDROXYUREA; MESYLIC ACID METHYL ESTER; PROTEIN P21; UBIQUITIN; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ENZYME INHIBITOR; MUTAGENIC AGENT;

ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; UBIQUITINATION; ULTRAVIOLET IRRADIATION; ULTRAVIOLET RADIATION; CELL CULTURE; CELL CYCLE; COLORECTAL TUMOR; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; LUNG TUMOR; METABOLISM; PATHOLOGY; RADIATION EXPOSURE;

ANTINEOPLASTIC AGENTS; APHIDICOLIN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA REPAIR; DOWN-REGULATION; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; HYDROXYUREA; LUNG NEOPLASMS; METHYL METHANESULFONATE; MUTAGENS; PROLIFERATING CELL NUCLEAR ANTIGEN; UBIQUITIN; ULTRAVIOLET RAYS;

EID: 33646156444     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209315     Document Type: Article

References (51)

1. Ashcroft M, Taya Y, Vousden KH. (2000). Mol Cell Biol 20: 3224-3233.
2. Baptiste N, Friedlander P, Chen X, Prives C. (2002). Oncogene 21: 9-21.
3. Bendjennat MBJ, Jascur T, Brickner H, Barbier V, Sarasin A, Fotedar A et al. (2003). Cell 114: 599-610.
4. Binz SK, Sheehan AM, Wold MS. (2004). DNA Repair (Amsterdam) 3: 1015-1024.
5. Blagosklonny MV, Wu GS, Omura S, el-Deiry WS. (1996). Biochem Biophys Res Commun 227: 564-569.
6. Bloom J, Amador V, Bartolini F, DeMartino G, Pagano M. (2003). Cell 115: 71-82.
7. Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, Hershko A. (2003). J Biol Chem 278: 25752-25757.
8. Carr AM. (2003). Science 300: 1512-1513.
9. Chen U, Chen S, Saha P, Dutta A. (1996). Proc Natl Acad Sci USA 93: 11597-11602.
10. Chuang LC, Yew PR. (2005). J Biol Chem 280: 35299-35309.
11. Cooper MP, Balajee AS, Bohr VA. (1999). Mol Biol Cell 10: 2119-2129.
12. Dotto GP. (2000). Biochim Biophys Acta 1471: M43-M56.
13. Frouin I, Toueille M, Ferrari E, Shevelev I, Hubscher U. (2005). Nucleic Acids Res 33: 5354-5361.
14. Furstenthal L, Swanson C, Kaiser BK, Eldridge AG, Jackson PK. (2001). Nat Cell Biol 3: 715-722.
15. Gary R, Ludwig DL, Cornelius HL, Maclnnes MA, Park MS. (1997). J Biol Chem 272: 24522-24529.
16. Gewirtz DA. (1999). Biochem Pharmacol 57: 727-741.
17. Gottifredi V, McKinney K, Poyurovsky MV, Prives C. (2004). J Biol Chem 279: 5802-5810.
18. Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M, Kuriyan J. (1996). Cell 87: 297-306.
19. Hammond EM, Denko NC, Dorie MJ, Abraham RT, Giaccia AJ. (2002). Mol Cell Biol 22: 1834-1843.
20. Hammond EM, Giaccia AJ. (2004). DNA Repair (Amst) 3: 1117-1122.
21. Hammond EM, Green SL, Giaccia AJ. (2003). Mutat Res 532: 205-213.
22. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. (2002). Nature 419: 135-141.
23. Ikegami S, Taguchi T, Ohashi M, Oguro M, Nagano H, Mano Y. (1978). Nature 275: 458-460.
24. Jonsson ZO, Hubscher U. (1997). Bioessays 19: 967-975.
25. Kannouche PL, Lehmann AR. (2004). Cell Cycle 3: 1011-1013.
26. Kannouche PL, Wing J, Lehmann AR. (2004). Mol Cell 14: 491-500.
27. Kelman Z. (1997). Oncogene 14: 629-640.
28. Kuhne C, Tjornhammar ML, Pongor S, Banks L, Simoncsits A. (2003). Nucleic Acids Res 31: 7227-7237.
29. Lakin ND, Jackson SP. (1999). Oncogene 18: 7644-7655.
30. Mc Donald III ER, Wu GS, Waldman T, El-Deiry WS. (1996). Cancer Res 56: 2250-2255.
31. Muller-Tidow C, Ji P, Diederichs S, Potratz J, Baumer N, Kohler G et al. (2004). Mol Cell Biol 24: 8917-8928.
32. Nikiforov A, Svetlova M, Solovjeva L, Sasina L, Siino J, Nazarov I et al. (2004). Biochem Biophys Res Commun 323: 831-837.
33. Oku T, Ikeda S, Sasaki H, Fukuda K, Morioka H, Ohtsuka E et al. (1998). Genes Cells 3: 357-369.
34. Pan ZQ, Reardon JT, Li L, Flores-Rozas H, Legerski R, Sancar A et al. (1995). J Biol Chem 270: 22008-22016.
35. Pickart CM. (2002). Nature 419: 120-121.
36. Podust VN, Podust LM, Goubin F, Ducommun B, Hubscher U. (1995). Biochemistry 34: 8869-8875.
37. Prelich G, Stillman B. (1988). Cell 53: 117-126.
38. Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, Clurman BE. (2000). Mol Cell 5: 403-410.
39. Sheikh MS, Chen YQ, Smith ML, Fornace Jr AJ. (1997). Oncogene 14: 1875-1882.
40. Shivji MK, Ferrari E, Ball K, Hubscher U, Wood RD. (1998). Oncogene 17: 2827-2838.
41. Shroff R, Arbel-Eden A, Pilch D, Ira G, Bonner WM, Petrini JH et al. (2004). Curr Biol 14: 1703-1711.
42. Sobell HM. (1985). Proc Natl Acad Sci USA 82: 5328-5331.
43. Solomon DA, Cardoso MC, Knudsen ES. (2004). J Cell Biol 166: 455-463.
44. Stelter P, Ulrich HD. (2003). Nature 425: 188-191.
45. Thyberg J, Moskalewski S. (1999). Exp Cell Res 246: 263-279.
46. Timson J. (1975). Mutat Res 32: 115-132.
47. Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J, Allday MJ. (2001). EMBO J 20: 2367-2375.
48. Treier M, Staszewski LM, Bohmann D. (1994). Cell 78: 787-798.
49. Waga S, Stillman B. (1998). Mol Cell Biol 18: 4177-4187.
50. Warbrick E. (2000). Bioessays 22: 997-1006.
51. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M. (2004). EMBO J 23: 3886-3896.